| | October 18, 2011 • Volume 8 / Number 20 |
The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Featured Article: Chemotherapy That is Less Toxic to the Heart May Be an Option for Some Women with HER2-Positive Breast Cancer »
- Higher-Dose Radiation Does Not Improve Survival in Some Lung Cancer Patients »
- BRCA Gene Mutations May Influence Survival, Treatment Response in Ovarian Cancer »
- Newer Cancer Drugs May Cause Thyroid to Function Abnormally »
- Bacterium Linked to Colorectal Cancer in Two Independent Studies »
- Vitamin E Supplements Tied to Increased Risk of Prostate Cancer »
- After DES: Tracking the Harms of a Prenatal Drug Exposure »
- Profiles in Cancer Research: Dr. Samuel Achilefu »
- Featured Clinical Trial: Bortezomib and Chemotherapy for Systemic Light-Chain Amyloidosis »
- Cancer Center Profile: Purdue University Center for Cancer Research »
Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov. |
Posts
